Related Experiment Video
Updated: Apr 24, 2026

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.3K
Glymphatic System Dysfunction in Epilepsy: Clinical and Translational Perspectives
Dong Ah Lee1, Ho-Joon Lee2, Kang Min Park1
1Department of Neurology, Haeundae Paik Hospital, Inje University College of Medicine, Busan, Republic of Korea.
Epilepsy Currents
|April 23, 2026
Summary
Epilepsy involves more than just neurons; impaired glymphatic system clearance of brain waste contributes to disease progression. Targeting this system may offer new epilepsy treatments.
Area of Science:
- Neuroscience
- Neurology
- Biomedical Engineering
Background:
- Epilepsy traditionally viewed as neuronal hyperexcitability.
- Emerging evidence links seizures to broader brain homeostasis disturbances (metabolic, inflammatory, vascular, sleep).
- Brain-wide clearance mechanisms, like the glymphatic system, are understudied in epilepsy.
Purpose of the Study:
- Review current knowledge of glymphatic system anatomy and physiology.
- Synthesize evidence of glymphatic dysfunction in epilepsy.
- Discuss clinical implications and therapeutic potential of glymphatic modulation.
Main Methods:
- Literature review focusing on glymphatic system function and dysfunction.
- Synthesis of neuroimaging advances related to glymphatic transport.
- Analysis of emerging evidence linking glymphatic impairment to epilepsy syndromes.
Main Results:
- Glymphatic system dysfunction is implicated across various epilepsy syndromes.
- Impaired waste clearance correlates with disease burden, cognitive decline, and treatment outcomes.
- Sleep-wake state significantly modulates glymphatic transport, relevant to epilepsy.
Conclusions:
- Glymphatic system dysfunction is a system-level abnormality in epilepsy.
- This offers a framework integrating metabolic, vascular, and sleep aspects of epilepsy.
- Modulating glymphatic function presents potential therapeutic strategies for epilepsy.
Related Concept Videos
Epilepsy and Seizures: Overview
1.7K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.7K
Epilepsy ll: Types
24
Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
24
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.7K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.7K
Cerebral Edema ll: Pathophysiology
7
Vasogenic edema is a major form of cerebral edema characterized by abnormal accumulation of fluid in the brain’s extracellular space due to disruption of the blood–brain barrier (BBB). The BBB is a specialized structure composed of endothelial cells connected by tight junctions, supported by astrocytic endfeet and a basement membrane. Under normal conditions, it tightly regulates the movement of ions, proteins, and solutes between the bloodstream and brain parenchyma. When this...
7
Seizures l: Introduction
27
Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
27
Seizures: Classification
2.4K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.4K

